Impact of Sunitinib on Human Thyroid Cancer Cells
Background/Aims: Thyroid cancer accounts for about 1% of all cancer cases. Multikinase inhibitors like sunitinib (S) have a promising potential in thyroid cancer therapy. Therefore, the principal aim of this study was to investigate the impact of sunitinib on the secretion of cytokines of follicular...
Main Authors: | Jirka Grosse, Elisabeth Warnke, Fabian Pohl, Nils E. Magnusson, Markus Wehland, Manfred Infanger, Christoph Eilles, Daniela Grimm |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2013-07-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/350132 |
Similar Items
-
A significant response to sunitinib in a patient with anaplastic thyroid carcinoma
by: Enrique Grande, et al.
Published: (2013-01-01) -
Early onset recall pneumonitis during targeted therapy with sunitinib
by: Yuasa Takeshi, et al.
Published: (2013-01-01) -
Cytokine Release and Focal Adhesion Proteins in Normal Thyroid Cells Cultured on the Random Positioning Machine
by: Elisabeth Warnke, et al.
Published: (2017-08-01) -
Sunitinib-Loaded MPEG-PCL Micelles for the Treatment of Age-Related Macular Degeneration
by: Jarriaun Streets, et al.
Published: (2020-07-01) -
Prognostic and predictive significance of VEGF, CD31, and Ang-1 in patients with metastatic clear cell renal cell carcinoma treated with first-line sunitinib
by: Marija Kraljević, et al.
Published: (2023-01-01)